Literature DB >> 5360813

Effects of propranolol on blood sugar, insulin and free fatty acids.

S P Allison, M J Chamberlain, J E Miller, R Ferguson, A P Gillett, B V Bemand, R A Saunders.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5360813     DOI: 10.1007/bf00452909

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  15 in total

1.  INTERPRETATION OF THE INTRAVENOUS GLUCOSE TEST.

Authors:  E SAMOLS; V MARKS
Journal:  Lancet       Date:  1965-02-27       Impact factor: 79.321

2.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

3.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

4.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

5.  The colorimetric micro-determination of long-chain fatty acids.

Authors:  W G Duncombe
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

6.  Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.

Authors:  E A Abramson; R A Arky; K A Woeber
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

7.  Receptor mechanisms in the hyperglycaemic response to adrenaline in man.

Authors:  A Antonis; M L Clark; R L Hodge; M Molony; T R Pilkington
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

8.  Propranolol and hypoglycaemia.

Authors:  T F Mackintosh
Journal:  Lancet       Date:  1967-01-14       Impact factor: 79.321

9.  Propranolol and hypoglycaemia.

Authors:  W S Reveno; H Rosenbaum
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

10.  Effect of acute muscular exercise on serum immunoreactive insulin concentration.

Authors:  B Cochran; E P Marbach; R Poucher; T Steinberg; G Gwinup
Journal:  Diabetes       Date:  1966-11       Impact factor: 9.461

View more
  12 in total

1.  Insulin secretion during oral treatment with beta-adrenergic blocking agents in diabetics.

Authors: 
Journal:  Acta Diabetol Lat       Date:  1976 Jan-Apr

2.  Can beta-blockers be used in diabetic patients?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

3.  The effect of propranolol on hypoglycaemia. Observations in five insulinoma patients.

Authors:  C Scandellari; M Zaccaria; C De Palo; N Sicolo; G Erle; G Federspil
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

4.  Intermittent hypoxia-induced glucose intolerance is abolished by α-adrenergic blockade or adrenal medullectomy.

Authors:  Jonathan C Jun; Mi-Kyung Shin; Ronald Devera; Qiaoling Yao; Omar Mesarwi; Shannon Bevans-Fonti; Vsevolod Y Polotsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-14       Impact factor: 4.310

Review 5.  Formulary considerations in selection of beta-blockers.

Authors:  K C Yedinak
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

Review 6.  Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 7.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.

Authors:  D C Simonson; V Koivisto; R S Sherwin; E Ferrannini; R Hendler; A Juhlin-Dannfelt; R A DeFronzo
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.

Authors:  K Tötterman; L Groop; P H Groop; R Kala; E M Tolppanen; F Fyhrquist
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Propranolol and blood glucose: simultaneous measurements over a wide range of doses and the effect of propranolol on the glucose tolerance test.

Authors:  D H Staniforth; N J Yorkston; M Gemidjioglu
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.